Together they complement each other, but either is better than neither
Beyond fat loss, Tesamorelin increases lean body mass by 1.42 kg across randomized clinical trials, improves lipid profiles (reducing triglycerides by 48 mg/dL and total cholesterol by 8 mg/dL at 52 weeks), and lowers hepatic fat fraction by 4.9% at 12 months in patients with NAFLD
It is recommended to stay at each Wegovy dose for at least four weeks
The LEAN trial specifically demonstrated histologic improvement in NASH patients, with resolution of NASH in 39% of liraglutide-treated patients
Boosts collagen production for firmness, elasticity, and a more youthful skin structure
indeed both -diversity indexes were inversely proportional to NR (F (1,58) = 5.85